According to The Insight Partners, the Radiotherapy Devices Market size is expected to reach US$ 13.99 Billion by 2034 from US$ 8.28 Billion in 2025. The market is estimated to record a CAGR of 6.01% from 2026 to 2034. The growth outlook reflects increasing cancer incidence, technological advancements in radiation treatment modalities, and growing demand for accurate and personalized cancer therapies. The market is segmented by product into external beam radiation therapy devices, including linear accelerators and proton therapy devices, and internal beam radiation therapy devices, including brachytherapy and other devices.
By end user, the market covers hospitals, ambulatory surgical centers, and cancer care centers. The total addressable market during 2026–2034 is projected at approximately US$ 100.91 Billion.
Download Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00007739
Radiotherapy Devices Market Size, Share, Trends, Analysis, and Forecast by 2034
- Market Size: US$ 8.28 Billion in 2025.
- Forecast Market Size: US$ 13.99 Billion by 2034.
- CAGR: 6.01% from 2026 to 2034.
- Addressable Market: Approximately US$ 100.91 Billion during 2026–2034.
- Market Share: North America held the dominant position in the global market in 2025.
- Key Trend: Rising adoption of image-guided radiation therapy.
- Technology Trend: Increasing integration of artificial intelligence into radiotherapy treatment planning and delivery.
- Product Segmentation: External beam radiation therapy devices and internal beam radiation therapy devices.
- External Beam Devices: Linear accelerators and proton therapy devices.
- Internal Beam Devices: Brachytherapy devices and other internal beam radiation therapy devices.
- End Users: Hospitals, ambulatory surgical centers, and cancer care centers.
- Growth Opportunities: Emerging-market expansion, advanced combination therapies, and increased research and development investment.
Radiotherapy Devices Market Trends
Several technological and clinical trends are shaping the radiotherapy devices market. Image-guided radiation therapy (IGRT) remains a major trend because advanced imaging can improve tumor targeting and treatment accuracy. Healthcare facilities are increasingly interested in technologies that can support precise radiation delivery while minimizing exposure to surrounding healthy tissue.
Artificial intelligence is another important development. AI-based technologies can assist with treatment planning and improve workflow efficiency by analyzing large volumes of patient data. The incorporation of AI into radiotherapy systems is expected to support more personalized treatment approaches and reduce opportunities for human error.
The market is also witnessing growing interest in compact and portable radiotherapy devices, particularly for outpatient and community healthcare settings. Such systems may help extend access to advanced cancer treatment in areas with limited resources. At the same time, adaptive radiotherapy and personalized treatment planning are encouraging manufacturers to increase research and development investments.
Market Analysis
The radiotherapy devices industry is positioned for sustained growth as healthcare providers seek advanced technologies capable of delivering effective and increasingly precise cancer treatment. Expansion of cancer-care infrastructure, improvements in radiation delivery, and technological convergence between imaging, software, artificial intelligence, and treatment systems are creating new opportunities for manufacturers.
The market also offers considerable potential in emerging economies, where cancer incidence is increasing and healthcare systems are expanding their access to advanced treatment modalities. Manufacturers that develop cost-effective, efficient, and adaptable radiotherapy systems can potentially address unmet demand in these markets. Furthermore, the combination of radiotherapy with immunotherapy, targeted therapy, and other cancer treatments represents an important opportunity for continued innovation.
Regional Analysis
North America: North America dominated the radiotherapy devices market in 2025, supported by advanced healthcare infrastructure, strong technology adoption, and established cancer-care facilities. The US is a key market, while Canada and Mexico also form part of the regional market landscape.
Europe: Europe represents another important market, with countries such as the UK, Germany, France, Russia, and Italy contributing to regional demand. Investments in advanced cancer treatment technologies and healthcare modernization are supporting market development.
Asia-Pacific: Asia-Pacific is expected to witness the fastest growth rate during the forecast period. Increasing cancer incidence, expanding healthcare infrastructure, improving access to advanced treatment technologies, and growing investments in cancer care are expected to create substantial opportunities across the region.
South and Central America: Brazil, Argentina, and other countries in the region are included in the market landscape, with improving healthcare infrastructure creating opportunities for advanced radiotherapy equipment.
Middle East and Africa: South Africa, Saudi Arabia, the UAE, and other countries are contributing to regional development as healthcare systems increasingly focus on improving cancer diagnosis and treatment capabilities.
Key Players in the Radiotherapy Devices Market
The major companies profiled in the Radiotherapy Devices Market include:
- Accuray Incorporated
- C.R. Bard, Inc.
- Elekta AB
- Hitachi Ltd.
- Ion Beam Applications SA
- Mevion Medical Systems, Inc.
- Panacea Medical Technologies Pvt. Ltd.
- Provision Healthcare
- Varian Medical Systems, Inc.
- ViewRay, Inc.
These companies are focusing on technological innovation, product development, strategic expansion, and research and development to strengthen their positions in the evolving radiotherapy devices landscape.
Get Premium Research Report Market Size and Report at:
https://www.theinsightpartners.com/buy/TIPRE00007739
Future Outlook
The outlook for the radiotherapy devices market remains positive through 2034. Increasing demand for precision cancer treatment, wider adoption of image-guided radiation therapy, AI integration, development of compact systems, and investment in adaptive and personalized treatment technologies are expected to support market growth. Expansion into emerging markets and development of combination treatment approaches could further broaden the addressable market. As healthcare providers continue prioritizing treatment accuracy, efficiency, and patient outcomes, radiotherapy device manufacturers are likely to focus on advanced platforms that integrate imaging, automation, software, and intelligent treatment planning.
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish
